ALX Oncology(ALXO) - 2025 Q2 - Earnings Call Presentation

Jason Lettmann | Chief Executive Officer Q2 2025 Results August 12, 2025 Jason Lettmann NASDAQ GS ALXO CEO, ALX Oncology © ALX Oncology Inc. All rights reserved. Forward-looking Statements Certain information set forth in this presentation contains "forward-looking information", under applicable laws collectively referred to herein as forward-looking statements. Except for statements of historical fact, information contained herein constitutes forward-looking statements and includes, but is not limited to t ...